Comment
doi: 10.4103/ijo.IJO_2782_21.
Commentary: Let us ponder - Choosing between topical Nepafenac and topical steroids after cataract surgery
Affiliations
- PMID: 35225520
- PMCID: PMC9114600
- DOI: 10.4103/ijo.IJO_2782_21
Item in Clipboard
Comment
Commentary: Let us ponder - Choosing between topical Nepafenac and topical steroids after cataract surgery
Indian J Ophthalmol.
2022 Mar.
No abstract available
Conflict of interest statement
None
Comment on
-
Comparison of once daily dose of 0.3% nepafenac alone and three times dose of 0.1% nepafenac alone in pain and inflammation control after phacoemulsification.Indian J Ophthalmol. 2022 Mar;70(3):807-812. doi: 10.4103/ijo.IJO_2401_21. Indian J Ophthalmol. 2022. PMID: 35225519 Free PMC article. Clinical Trial.
Similar articles
-
Prophylaxis of macular edema after cataract surgery in diabetic patients, topical Nepafenac versus intravitreal Ranibizumab.Eur J Ophthalmol. 2022 Jan;32(1):205-212. doi: 10.1177/11206721211001275. Epub 2021 Mar 16. Eur J Ophthalmol. 2022. PMID: 33726537 Clinical Trial.
-
Comparison of preoperative nepafenac (0.1%) and flurbiprofen (0.03%) eye drops in maintaining mydriasis during small incision cataract surgery in patients with senile cataract: A randomized, double-blind study.Indian J Pharmacol. 2015 Sep-Oct;47(5):491-5. doi: 10.4103/0253-7613.165201. Indian J Pharmacol. 2015. PMID: 26600636 Free PMC article. Clinical Trial.
-
0.1% Nepafenac reduces pain and increases patient comfort during cataract surgery.Cont Lens Anterior Eye. 2018 Oct;41(5):448-451. doi: 10.1016/j.clae.2018.05.003. Epub 2018 May 26. Cont Lens Anterior Eye. 2018. PMID: 29807771
-
Ocular permeation and inhibition of retinal inflammation: an examination of data and expert opinion on the clinical utility of nepafenac.Curr Med Res Opin. 2006 Feb;22(2):397-404. doi: 10.1185/030079906X89775. Curr Med Res Opin. 2006. PMID: 16466612 Review.
-
Nepafenac: an ophthalmic nonsteroidal antiinflammatory drug for pain after cataract surgery.Ann Pharmacother. 2013 Jun;47(6):892-6. doi: 10.1345/aph.1R757. Epub 2013 May 28. Ann Pharmacother. 2013. PMID: 23715071 Review.
References
-
- Jampol LM, Jain S, Weinreb RN. Non steroidal anti-inflammatory drugs and cataract surgery. Arch Ophthalmol. 1994;112:891–4. - PubMed
-
- Gamache DA, Graff G, Brady MT, Spellman JM, Yanni JM. Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular infl ammation:I. Assessment of anti-inflammatory efficacy. Inflammation. 2000;24:357–70. - PubMed
-
- Chu CJ, Johnston RL, Buscombe C, Sallam AB, Mohamed Q, Yang YC. United Kingdom Pseudophakic Macular Edema study group risk factors and incidence of macular edema after cataract surgery:A database study of 81984 eyes. Ophthalmology. 2016;123:316–23. - PubMed
-
- Boscia F, Giancipoli E, D'Amico Ricci G, Pinna A. Management of macular oedema in diabetic patients undergoing cataract surgery. Curr Opin Ophthalmol. 2017;28:23–8. - PubMed
-
- Gaynes BI, Fiscella R. Topical nonsteroidal anti- inflammatory drugs for ophthalmic use. Drug Safety. 2002;25:2334–50. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
